Clinical Trials Logo

Smith-Kingsmore Syndrome clinical trials

View clinical trials related to Smith-Kingsmore Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT04395495 Recruiting - Neurofibromatosis 1 Clinical Trials

RASopathy Biorepository

Start date: June 27, 2017
Phase:
Study type: Observational [Patient Registry]

The RASopathies are a group of developmental disorders caused by genetic changes in the genes that compose the Ras/mitogen activated protein kinase (MAPK) pathway. New RASopathies are being diagnosed frequently. This pathway is essential in the regulation of the cell cycle and the determination of cell function. Thus, appropriate function of this pathway is critical to normal development. Each syndrome in this group of disorders has unique phenotypic features, but there are many overlapping features including facial features, heart defects, cutaneous abnormalities, cognitive delays, and a predisposition to malignancies. This research study proposes to collect and store human bio-specimens from patients with suspected or diagnosed RASopathies. Once obtained, blood and/or tissue samples will be processed for: metabolic function studies, biomarkers, genetic studies, and/or the establishment of immortalized cell lines. In addition, data from the medical record (including neuropsychological evaluations) and surveys will be stored to create a longitudinal database for research conducted at CCHMC or at other research institutions.